Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AGEN1181
Trade Name
Synonyms AGEN 1181|AGEN-1181|Botensilimab
Drug Descriptions

AGEN1181 is an antibody that targets CTLA4, potentially resulting in increased anti-tumor immune response (NCI Drug Dictionary).

DrugClasses CTLA4 Antibody 24 Immune Checkpoint Inhibitor 153
CAS Registry Number NA
NCIT ID C158557


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
AGEN1181 AGEN1181 0 3
AGEN1181 + AGEN1571 AGEN1181 AGEN1571 0 1
AGEN1181 + AGEN1571 + Balstilimab AGEN1181 AGEN1571 Balstilimab 0 1
AGEN1181 + Balstilimab AGEN1181 Balstilimab 0 2
AGEN1181 + Balstilimab + Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin AGEN1181 Balstilimab Bevacizumab Fluorouracil Leucovorin Oxaliplatin 0 1
AGEN1181 + Balstilimab + Regorafenib AGEN1181 Balstilimab Regorafenib 0 1
AGEN1181 + Gemcitabine + Nab-paclitaxel AGEN1181 Gemcitabine Nab-paclitaxel 0 1

Additional content available in CKB BOOST